Fundz

Ensoma Appoints Jon Garen as Chief Corporate Development and Business Officer

PRIVATEOct 28, 2024

Position

Chief Corporate Development Officer

Company

Ensoma

Jon Garen
BostonBiotechnologyHealth Care

Description

Ensoma announced the appointment of Jon Garen as chief corporate development and business officer. Jon's exceptional track record in genetic medicines and business development will be instrumental in driving Ensoma’s growth as they transition to a clinical-stage company with their groundbreaking in vivo HSC-targeting platform.

Quick answer

Ensoma Appoints Jon Garen as Chief Corporate Development and Business Officer (October 28, 2024). Ensoma is based in Boston, Massachusetts, United States.

Who is the new Chief Corporate Development Officer at Ensoma?
Ensoma named Jon Garen Chief Corporate Development Officer, announced October 28, 2024.
What did Ensoma announce on October 28, 2024?
Ensoma announced the appointment of Jon Garen as chief corporate development and business officer. Jon's exceptional track record in genetic medicines and business development will be instrumental in driving Ensoma’s growth as they transition to a clinical-stage company with their groundbreaking in vivo HSC-targeting platform.
What does Ensoma do?
Ensoma is developing potentially curative medicines for genetic diseases, immune disorders and cancer through in vivo hematopoietic stem cells (HSCs) engineering.
Where is Ensoma based?
Ensoma is based in Boston, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
AGC Biologics (October 28, 2024), Actinogen Medical (October 29, 2024), Canopy (October 29, 2024) and The Leukemia & Lymphoma Society (October 29, 2024) also announced leadership changes within 45 days of Ensoma.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Ensoma, and when

A new leader at Ensoma brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Ensoma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ensoma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ensoma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ensoma

Location

Boston, Massachusetts, United States

About

Ensoma is developing potentially curative medicines for genetic diseases, immune disorders and cancer through in vivo hematopoietic stem cells (HSCs) engineering. Our platform combines proprietary base editing or high-efficiency gene integration systems with high-capacity virus-like particles (VLPs) toward our goal of providing one-time administration of durable genetic medicines. The delivery system is based on VLPs that preferentially bind to HSCs, delivering DNA to the nucleus. With a 35-kilobase cargo capacity, these VLPs can carry a diverse range of sophisticated genomic engineering tools capable of introducing changes from single base edits to large multi-gene insertions, along with control elements for HSC-lineage cell specific expression. Ensoma is supported by top-tier investors and a passionate team committed to a bold, global vision for genetic medicines.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ensoma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Chapman
Senior decision-maker at this company
••••••••@••••••••

See Chapman's verified email →

Jim
Likely contact at this company
••••••••@••••••••

See Jim's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Ensoma's next move

Learn about Strategic plan

Ensoma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.